Page 3 - ஸ்டோவர்ஸ் நிறுவனம் க்கு மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article CLEVELAND, May 20, 2021 /PRNewswire/ Complion has developed a best-in-breed Shared Investigator Platform (SIP) integration in partnership with The University of Kansas Cancer Center (KU Cancer Center), which will be readily available across all Complion sites, including the largest base of more than 14,000 clinical trials. This integration will provide a single standard method for KU Cancer Center to work across the numerous major sponsors it works with on clinical research studies. The integration is the final step necessary to enable KU Cancer Center to fully adopt SIP and achieve the benefits of faster feasibility as well as securing additional studies by eliminating objections from specific sponsors while becoming favorable for other sponsors seeking sites for their studies.

Rick arlowUniversity of kansasUniversity of kansas medical centerStowers institute for medical researchRegulatory affairsUniversity of kansas health systemMasonic cancer allianceUniversity of kansas cancer centerKu cancer centerJoseph hinesKansas cancer centerKansas medical centerKansas health systemStowers instituteMedical researchMasonic cancer